Dash Bio

Provider of automated bioanalysis platform for accelerated clinical drug development

placeBoston, Massachusetts, United States calendar_todayFounded 2024 language dash.bio

Social engagement

Social engagement: 6K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Freestyle, The Aligned Fund.

Investor typeCountShare
Venture capital571%
Other / undisclosed229%

Recent activity

30 Jun 2026
Leadership hire
Marketing Director
23 Jun 2026
Event
Moderated by Ander Tallett
18 Jun 2026
Event
Transforming Bioanalysis through Automation
Coming soon